Women-founded company partners with CU Anschutz to develop, test first-of-its-kind ovarian cancer detection test
Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the ...
Corcept's ovarian cancer drug meets main goal in late-stage study, shares jump
Corcept Therapeutics said on Monday its experimental combination ovarian cancer drug improved survival in patients with a ...
GlobalData on MSN17h
Corcept’s Phase III trial of ovarian cancer therapy shows PFS improvement
The trial outcomes are said to support a new drug application in the US and a European marketing authorisation application.
A common blood test for ovarian cancer is more likely to fall short for Black and Native American women
A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
EurekAlert!1d
TRIM4 modulates the ubiquitin-mediated degradation of hnRNPDL and weakens sensitivity to CDK4/6 inhibitor in ovarian cancer
Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, ...
The Healthy @Reader's Digest5d
“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily Exercise
A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...
Explore more
Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...
The Associated Press on MSN12d
Blood test for ovarian cancer misses some Black, Native American patients: Study
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...
WebMD11d
What to Know About Ovarian Cancer Recurrence
After you’ve gone through ovarian cancer treatment, your doctor will work with you to make sure you stay well. But sometimes the cancer returns. Doctors call this “recurrence.” To check for ...